SPINK1 and cancer: The IPA summary of contralateral PTE+ cortical astrocytes shows predicted activation of serine peptidase inhibitor Kazal type 1 (SPINK1) general cancer pathway, as well as IL-15 production, KLF4, SOX4 and migration of phagocytes/myeloid cells (Fig. 3D).